BD DISCARDIT¿ II SYRINGE 20ML
Report
- Report Number
- 3002682307-2022-00157
- Event Type
- Malfunction
- Date Received
- June 8, 2022
- Date of Event
- April 25, 2022
- Report Date
- November 7, 2022
- Manufacturer
- BECTON DICKINSON, S.A.
- Product Code
- FMF
- PMA / PMN Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES. D10: RETURNED TO MANUFACTURER ON: 21-OCT-2022 . H6: INVESTIGATION SUMMARY A DEVICE HISTORY RECORD REVIEW WAS COMPLETED FOR PROVIDED MATERIAL NUMBER 300296 AND LOT NUMBER 2202167. THE REVIEW DID NOT REVEAL ANY DETECTED ABNORMALITIES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THE REPORTED DEFECT AND ALL QUALITY TESTS WERE FOUND TO BE WITHIN SPECIFICATION. TO AID IN THE INVESTIGATION OF THIS ISSUE, THE AFFECTED SAMPLE WAS RETURNED FOR EVALUATION BY OUR QUALITY ENGINEER TEAM. THROUGH EXAMINATION OF THE SAMPLE, LEAKAGE WAS OBSERVED. TWENTY RETAINED SAMPLES WERE ALSO OBTAINED FOR EVALUATION; HOWEVER, THE RETAINED SAMPLES DID NOT SHOW ANY SIGNS OF LEAKAGE. BASED ON THE RETURNED SAMPLE RESULTS, THE LEAKAGE RESULTED FROM DAMAGE TO THE PLUNGER LIP COMPONENT. THIS TYPE OF DAMAGE MAY OCCUR DURING THE HANDLING OF THE PRODUCT THROUGH THE MANUFACTURING PROCESS OR WITHIN THE PLUNGER ASSEMBLY MACHINE.
IT WAS REPORTED BY THE CUSTOMER THAT DURING USE THE INJECTION OF THE PRODUCT INFILTRATED THE BODY OF THE BD DISCARDIT¿ II SYRINGE 20ML ON THE PLUNGER SIDE, WITH A LOSS OF APPROXIMATELY 1ML OF PRODUCT, FROM WHICH THE PATIENT DID NOT BENEFIT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE WITHDRAWAL OF MEDICATION (LIORESAL) BY SYRINGE WAS CARRIED OUT WITHOUT ANY PROBLEM, BUT THE INJECTION OF THE SAME PRODUCT WITH THE SYRINGE INTO THE RESERVOIR OF AN IMPLANTABLE PROGRAMMABLE INFUSION PUMP POSED THE FOLLOWING PROBLEM: DURING THE INJECTION THE PRODUCT INFILTRATED THE BODY OF THE SYRINGE ON THE PLUNGER SIDE, WITH A LOSS OF APPROXIMATELY 1ML OF PRODUCT, FROM WHICH THE PATIENT DID NOT BENEFIT."
IT WAS REPORTED BY THE CUSTOMER THAT DURING USE THE INJECTION OF THE PRODUCT INFILTRATED THE BODY OF THE BD DISCARDIT¿ II SYRINGE 20ML ON THE PLUNGER SIDE, WITH A LOSS OF APPROXIMATELY 1ML OF PRODUCT, FROM WHICH THE PATIENT DID NOT BENEFIT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE WITHDRAWAL OF MEDICATION (LIORESAL) BY SYRINGE WAS CARRIED OUT WITHOUT ANY PROBLEM, BUT THE INJECTION OF THE SAME PRODUCT WITH THE SYRINGE INTO THE RESERVOIR OF AN IMPLANTABLE PROGRAMMABLE INFUSION PUMP POSED THE FOLLOWING PROBLEM: DURING THE INJECTION THE PRODUCT INFILTRATED THE BODY OF THE SYRINGE ON THE PLUNGER SIDE, WITH A LOSS OF APPROXIMATELY 1ML OF PRODUCT, FROM WHICH THE PATIENT DID NOT BENEFIT."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 678758 | BD DISCARDIT¿ II SYRINGE 20ML | PISTON SYRINGE | FMF | BECTON DICKINSON, S.A. | 2202167 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |